Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome
Conditions: Kaposiform Hemangioendothelioma; Kasabach Merritt Phenomenon Interventions: Drug: Sirolimus; Drug: Prednisolone Sponsor: West China Hospital Recruiting - verified June 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials